论文部分内容阅读
利用体内体外试验观察了中药“抗癌灵”对具有较强侵袭力的小鼠低分化肝癌(HCa-p)的杀伤及抑制作用。抗癌灵2号及抗癌灵3号浓度达到02g/ml时,在体外对瘤细胞的杀伤率均达100%;它们对移植瘤的抑制率分别为334%和358%,后者与对照组有显著差异(P<005)。抗癌灵3号对肝、心、肾均无明显毒性。结果说明抗癌灵3号对小鼠肝癌有一定治疗作用,且毒副作用小,可作为临床应用的参考。
The in vitro and in vivo experiments were performed to observe the killing and inhibiting effects of the traditional Chinese medicine “Anti-cancer spirit” on poorly-differentiated liver cancer (HCa-p) in mice with strong invasiveness. When the concentration of Kangailing 2 and Kangailing 3 reached 02g/ml, the killing rate of tumor cells in vitro reached 100%; their inhibitory rates to transplanted tumors were 334% and 358, respectively. %, the latter was significantly different from the control group (P < 0.05). Anti-cancer spirit No. 3 had no obvious toxicity to liver, heart and kidney. The results showed that Kangailing 3 has a certain therapeutic effect on liver cancer in mice, and has little side effects, which can be used as a reference for clinical application.